YAMAGATA Tatsufumi
   Department   Ritsumeikan Asia Pacific University  College of Asia Pacific Studies
   Position   Professor
Language Japanese
Publication Date 2022/07/31
Type Research paper
Peer Review Peer reviewed
Invitation Invited paper
Title Centralized and Decentralized Supplies of COVID-19 Vaccines to Developing Countries: Both COVAX and Competition Motivated by Vaccine Diplomacy Play Each Role (in Japanese)
Contribution Type Single Work
Journal Kokusai Keizai (International Economy)
Journal TypeJapan
Publisher Japan Society of International Economics
Volume, Issue, Page 73,pp.155-184
Total page number 30
Author and coauthor Tatsufumi Yamagata
Details 2001 WTO Doha Declaration and Advance Market Commitment (AMC), which were both designed to promote supply of medicines and vaccines for HIV/AIDS and neglected tropical diseases in the beginning of this century, were applied for furthering COVID-19 vaccine supply to developing countries in 2021. AMC was developed into COVAX, which is a COVID-19 vaccine distribution mechanism. Both COVAX and self-motivated vaccine developers individually contributed to swift inventions of a variety of COVID-19 vaccines and considerably low prices of them. The centralized policy instrument, ­i.e. COVAX, and decentralized innovation activities made by private pharmaceuticals firms, played important and reinforcing roles each other.
DOI 10.5652/kokusaikeizai.kk2022.f06
ISBN 9784879747815
ISSN 0387-3943
URL for researchmap https://doi.org/10.5652/kokusaikeizai.kk2022.f06